These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 2978401)

  • 1. [Effect of dermatan sulphate on plasminogen activator activity in perfused rat hindlegs].
    Zhu GJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Dec; 10(6):435-8. PubMed ID: 2978401
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermatan sulphate induces plasminogen activator release in the perfused rat hindquarters.
    Abbadini M; Zhu GJ; Maggi A; Pangrazzi J; Donati MB; Mussoni L
    Blood; 1987 Dec; 70(6):1858-60. PubMed ID: 3676516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
    Castañon MM; Gamba C; Kordich LC
    Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatan sulfate as a potential antithrombotic drug.
    Pangrazzi J; Gianese F
    Haematologica; 1987; 72(5):459-64. PubMed ID: 3121470
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of fasting and time of day on the urinary excretion of chondroitin 4/6 sulphate, dermatan sulphate and four chondroitinase ABC resistant glycosaminoglycans.
    Poulsen JH; Gregersen H
    Scand J Clin Lab Invest; 1983 Dec; 43(8):665-70. PubMed ID: 6420878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of hyaluronic acid, dermatan sulphate, heparan sulphate and chondroitin 4/6 sulphate in human dermis, and a material of reference.
    Poulsen JH; Cramers MK
    Scand J Clin Lab Invest; 1982 Nov; 42(7):545-9. PubMed ID: 6218602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of heparin cofactor II by heparin and dermatan sulfate.
    Tollefsen DM
    Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine diphosphate stimulates the endothelial release of tissue-type plasminogen activator but not von Willebrand factor from isolated-perfused rat hind limbs.
    Smalley DM; Fitzgerald JE; O'Rourke J
    Thromb Haemost; 1993 Dec; 70(6):1043-6. PubMed ID: 8165598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical properties of reconstituted collagen fibrils. Influence of a glycosaminoglycan: dermatan sulfate.
    Danielsen CC
    Connect Tissue Res; 1982; 9(4):219-25. PubMed ID: 6215205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
    Merton RE; Thomas DP
    Thromb Haemost; 1987 Oct; 58(3):839-42. PubMed ID: 3433248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal mucosal mast cells from rats infected with Nippostrongylus brasiliensis contain protease-resistant chondroitin sulfate di-B proteoglycans.
    Stevens RL; Lee TD; Seldin DC; Austen KF; Befus AD; Bienenstock J
    J Immunol; 1986 Jul; 137(1):291-5. PubMed ID: 3086452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oversulfated chondroitin-6-sulfate or oversulfated fucoidan in the activation of glutamic plasminogen by tissue plasminogen activator: role of lysine and cyanogen bromide-fibrinogen.
    Carranza YE; Anderson D; Doctor V
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):60-5. PubMed ID: 18180617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatan sulfate isomers in human articular cartilage characterized by high-performance liquid chromatography.
    Murata K; Yokoyama Y
    Biochem Int; 1987 Jul; 15(1):87-94. PubMed ID: 3453690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hirudin on the thrombin-induced release of tissue plasminogen activator from isolated perfused pig ear.
    Klöcking HP; Hoffmann A; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):110-2. PubMed ID: 2459003
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities.
    Du HY; Ji SL; Song HF; Ye QN; Cao JC
    Thromb Res; 2007; 119(3):377-84. PubMed ID: 17097136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of glycosaminoglycans on coagulation: a thromboelastographic study.
    Senzolo M; Coppell J; Cholongitas E; Riddell A; Triantos CK; Perry D; Burroughs AK
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):227-36. PubMed ID: 17413758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of submicrogram quantities of hyaluronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and Stains-All.
    Volpi N; Maccari F; Titze J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):131-5. PubMed ID: 15866501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate.
    Fabiana Alberto M; Giaquinta Romero D; Lazzari M; Calabrese GC
    Thromb Res; 2008; 122(1):109-16. PubMed ID: 17936880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycans in early chick embryo.
    Skandalis SS; Theocharis AD; Papageorgakopoulou N; Zagris N
    Int J Dev Biol; 2003 May; 47(4):311-4. PubMed ID: 12755338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-plasminogen activator restores muscle flap perfusion in the rat.
    Krapohl BD; Siemionow M; Zins JE
    J Hand Surg Am; 1999 Sep; 24(5):1036-44. PubMed ID: 10509283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.